Abilities of berberine and chemically modified berberines to inhibit proliferation of pancreatic cancer cells

Abrams, S.; Follo, M.; Steelman, L.; Lertpiriyapong, K.; Cocco, L.; Ratti, S.; Martelli, A.; Candido, S.; Libra, M.; Murata, R.; Rosalen, P.; Cervello, M.; Gizak, A.; Rakus, D.; Mao, W.; Lombardi, P.; Mccubrey, J.

Risultato della ricerca: Article

4 Citazioni (Scopus)

Abstract

Berberine (BBR) is a common nutraceutical consumed by millions worldwide. BBR has many different effects on human health, e.g., diabetes, diarrhea, inflammation and now more recently it has been proposed to have potent anti-cancer effects. BBR has been shown to suppress the growth of cancer cells more than normal cells. BBR has been proposed to exert its growth-inhibitory effects by many different biochemical mechanisms including: suppression of cell cycle progression, induction of reactive oxygen species, induction of apoptosis and autophagy and interactions with DNA potentially leading to DNA damage, and altered gene expression. Pancreatic cancer is a leading cancer worldwide associated with a poor prognosis. As our population ages, pancreatic cancer has an increasing incidence and will likely become the second leading cause of death from cancer. There are few truly-effective therapeutic options for pancreatic cancer. Surgery and certain chemotherapeutic drugs are used to treat pancreatic cancer patients. Novel approaches to treat pancreatic cancer patients are direly needed as they usually survive for less than a year after being diagnosed. In the following manuscript, we discuss the abilities of BBR and certain chemically-modified BBRs (NAX compounds) to suppress growth of pancreatic cancer cells.
Lingua originaleEnglish
pagine (da-a)172-182
Numero di pagine11
RivistaAdvances in Biological Regulation
Volume71
Stato di pubblicazionePublished - 2019

Cita questo

Abrams, S.; Follo, M.; Steelman, L.; Lertpiriyapong, K.; Cocco, L.; Ratti, S.; Martelli, A.; Candido, S.; Libra, M.; Murata, R.; Rosalen, P.; Cervello, M.; Gizak, A.; Rakus, D.; Mao, W.; Lombardi, P.; Mccubrey, J. (2019). Abilities of berberine and chemically modified berberines to inhibit proliferation of pancreatic cancer cells. Advances in Biological Regulation, 71, 172-182.

Abilities of berberine and chemically modified berberines to inhibit proliferation of pancreatic cancer cells. / Abrams, S.; Follo, M.; Steelman, L.; Lertpiriyapong, K.; Cocco, L.; Ratti, S.; Martelli, A.; Candido, S.; Libra, M.; Murata, R.; Rosalen, P.; Cervello, M.; Gizak, A.; Rakus, D.; Mao, W.; Lombardi, P.; Mccubrey, J.

In: Advances in Biological Regulation, Vol. 71, 2019, pag. 172-182.

Risultato della ricerca: Article

Abrams, S.; Follo, M.; Steelman, L.; Lertpiriyapong, K.; Cocco, L.; Ratti, S.; Martelli, A.; Candido, S.; Libra, M.; Murata, R.; Rosalen, P.; Cervello, M.; Gizak, A.; Rakus, D.; Mao, W.; Lombardi, P.; Mccubrey, J. 2019, 'Abilities of berberine and chemically modified berberines to inhibit proliferation of pancreatic cancer cells' Advances in Biological Regulation, vol. 71, pagg. 172-182.
Abrams, S.; Follo, M.; Steelman, L.; Lertpiriyapong, K.; Cocco, L.; Ratti, S.; Martelli, A.; Candido, S.; Libra, M.; Murata, R.; Rosalen, P.; Cervello, M.; Gizak, A.; Rakus, D.; Mao, W.; Lombardi, P.; Mccubrey, J. Abilities of berberine and chemically modified berberines to inhibit proliferation of pancreatic cancer cells. Advances in Biological Regulation. 2019;71:172-182.
Abrams, S.; Follo, M.; Steelman, L.; Lertpiriyapong, K.; Cocco, L.; Ratti, S.; Martelli, A.; Candido, S.; Libra, M.; Murata, R.; Rosalen, P.; Cervello, M.; Gizak, A.; Rakus, D.; Mao, W.; Lombardi, P.; Mccubrey, J. / Abilities of berberine and chemically modified berberines to inhibit proliferation of pancreatic cancer cells. In: Advances in Biological Regulation. 2019 ; Vol. 71. pagg. 172-182.
@article{4e0c8d378c444a95b35036ba6dd55ba3,
title = "Abilities of berberine and chemically modified berberines to inhibit proliferation of pancreatic cancer cells",
abstract = "Berberine (BBR) is a common nutraceutical consumed by millions worldwide. BBR has many different effects on human health, e.g., diabetes, diarrhea, inflammation and now more recently it has been proposed to have potent anti-cancer effects. BBR has been shown to suppress the growth of cancer cells more than normal cells. BBR has been proposed to exert its growth-inhibitory effects by many different biochemical mechanisms including: suppression of cell cycle progression, induction of reactive oxygen species, induction of apoptosis and autophagy and interactions with DNA potentially leading to DNA damage, and altered gene expression. Pancreatic cancer is a leading cancer worldwide associated with a poor prognosis. As our population ages, pancreatic cancer has an increasing incidence and will likely become the second leading cause of death from cancer. There are few truly-effective therapeutic options for pancreatic cancer. Surgery and certain chemotherapeutic drugs are used to treat pancreatic cancer patients. Novel approaches to treat pancreatic cancer patients are direly needed as they usually survive for less than a year after being diagnosed. In the following manuscript, we discuss the abilities of BBR and certain chemically-modified BBRs (NAX compounds) to suppress growth of pancreatic cancer cells.",
author = "{Abrams, S.; Follo, M.; Steelman, L.; Lertpiriyapong, K.; Cocco, L.; Ratti, S.; Martelli, A.; Candido, S.; Libra, M.; Murata, R.; Rosalen, P.; Cervello, M.; Gizak, A.; Rakus, D.; Mao, W.; Lombardi, P.; Mccubrey, J.} and Giuseppe Montalto",
year = "2019",
language = "English",
volume = "71",
pages = "172--182",
journal = "Advances in Biological Regulation",
issn = "2212-4926",
publisher = "Elsevier BV",

}

TY - JOUR

T1 - Abilities of berberine and chemically modified berberines to inhibit proliferation of pancreatic cancer cells

AU - Abrams, S.; Follo, M.; Steelman, L.; Lertpiriyapong, K.; Cocco, L.; Ratti, S.; Martelli, A.; Candido, S.; Libra, M.; Murata, R.; Rosalen, P.; Cervello, M.; Gizak, A.; Rakus, D.; Mao, W.; Lombardi, P.; Mccubrey, J.

AU - Montalto, Giuseppe

PY - 2019

Y1 - 2019

N2 - Berberine (BBR) is a common nutraceutical consumed by millions worldwide. BBR has many different effects on human health, e.g., diabetes, diarrhea, inflammation and now more recently it has been proposed to have potent anti-cancer effects. BBR has been shown to suppress the growth of cancer cells more than normal cells. BBR has been proposed to exert its growth-inhibitory effects by many different biochemical mechanisms including: suppression of cell cycle progression, induction of reactive oxygen species, induction of apoptosis and autophagy and interactions with DNA potentially leading to DNA damage, and altered gene expression. Pancreatic cancer is a leading cancer worldwide associated with a poor prognosis. As our population ages, pancreatic cancer has an increasing incidence and will likely become the second leading cause of death from cancer. There are few truly-effective therapeutic options for pancreatic cancer. Surgery and certain chemotherapeutic drugs are used to treat pancreatic cancer patients. Novel approaches to treat pancreatic cancer patients are direly needed as they usually survive for less than a year after being diagnosed. In the following manuscript, we discuss the abilities of BBR and certain chemically-modified BBRs (NAX compounds) to suppress growth of pancreatic cancer cells.

AB - Berberine (BBR) is a common nutraceutical consumed by millions worldwide. BBR has many different effects on human health, e.g., diabetes, diarrhea, inflammation and now more recently it has been proposed to have potent anti-cancer effects. BBR has been shown to suppress the growth of cancer cells more than normal cells. BBR has been proposed to exert its growth-inhibitory effects by many different biochemical mechanisms including: suppression of cell cycle progression, induction of reactive oxygen species, induction of apoptosis and autophagy and interactions with DNA potentially leading to DNA damage, and altered gene expression. Pancreatic cancer is a leading cancer worldwide associated with a poor prognosis. As our population ages, pancreatic cancer has an increasing incidence and will likely become the second leading cause of death from cancer. There are few truly-effective therapeutic options for pancreatic cancer. Surgery and certain chemotherapeutic drugs are used to treat pancreatic cancer patients. Novel approaches to treat pancreatic cancer patients are direly needed as they usually survive for less than a year after being diagnosed. In the following manuscript, we discuss the abilities of BBR and certain chemically-modified BBRs (NAX compounds) to suppress growth of pancreatic cancer cells.

UR - http://hdl.handle.net/10447/357819

M3 - Article

VL - 71

SP - 172

EP - 182

JO - Advances in Biological Regulation

JF - Advances in Biological Regulation

SN - 2212-4926

ER -